The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories recalls Tolterodine Tartrate Extended-Release Capsules
FDA Class III
FDA classified this recall as Class III: the product is unlikely to cause health problems but breaks the agency's rules (a labeling mistake, for example).
- Hazard
- Failed Dissolution Specifications: Out of specification results obtained during routine stability testing for dissolution.
- Products
-
- Tolterodine Tartrate Extended-Release Capsules
- Where it was sold
-
Nationwide in the USA
Nationwide
- Units affected
- 224 cartons
- About this recall
- Tolterodine Tartrate Extended-Release Capsules, 2 mg, 30 Capsules (3 x 10) Unit Dose carton, Rx only, Packaged and Distributed by: Major Pharmaceuticals, Indianapolis, IN 46268 USA, NDC 0904-6592-04.